Targeting nanoparticles to malignant tumors (Englisch)
- Neue Suche nach: Sharma, Nikita
- Neue Suche nach: Bietar, Kais
- Neue Suche nach: Stochaj, Ursula
- Neue Suche nach: Sharma, Nikita
- Neue Suche nach: Bietar, Kais
- Neue Suche nach: Stochaj, Ursula
In:
Biochimica et Biophysica Acta - Reviews on Cancer
;
1877
, 3
;
2022
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Targeting nanoparticles to malignant tumors
-
Beteiligte:
-
Erschienen in:
-
Verlag:
- Neue Suche nach: Elsevier B.V.
-
Erscheinungsdatum:21.02.2022
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:Nanomaterials , Cancer , Theranostics , Nanoparticle targeting , Ab , antibody , Ag , silver , AJ , adherens junction , Au , gold , BCSFB , blood-cerebrospinal fluid barrier , BBB , blood-brain barrier , BRB , blood-retina barrier , BTB , blood-tumor barrier , CAF , cancer-associated fibroblast , CD-M6PR , cation dependent M6PR , CD13 , aminopeptidase N, alanyl-aminopeptidase, membrane, LAP1 , CD16 , Fcγ receptor III, immunoglobulin γ (IgG) Fc region receptor III , CD44 , heparan sulfate proteoglycan, hyaluronate receptor , CD46 , complement regulatory protein, membrane cofactor protein, MCP , CD54 , intercellular adhesion molecule 1, ICAM-1 , CD62P , P-selectin, SELP , CD133 , prominin, PROM1 , CD146 , melanoma cell adhesion molecule, cell surface glycoprotein MUC18 , CD147 , basigin, OK blood group antigen , CD206 , mannose receptor C type 1, MRC1 , CD271 , nerve growth factor receptor (NGFR) , CEA , carcinoembryonic antigen, CEACAM5, CD66e , CI-M6PR , cation independent M6PR , CNS , central nervous system , CPP , cell penetrating peptide , CSF , cerebrospinal fluid , CXCR4 , C-X-C motif chemokine receptor 4 , EC , endothelial cell , ECM , extracellular matrix , EGF , epidermal growth factor , EGFR , EGF receptor , EpCAM , epithelial cellular adhesion molecule , EphA2 , ephrin receptor A2 , EPR , enhanced permeability and retention , ERBB2 , ERBB2 receptor tyrosine kinase 2, HER2 , FGF , fibroblast growth factor , FGFR , fibroblast growth factor receptor , FOLR , folate receptor , GLUT1 , solute carrier family 2 member 1 , GRPR , gastrin-releasing peptide receptor , GI , gastrointestinal , GnRHR , gonadotropin releasing hormone receptor, luteinizing hormone-releasing hormone receptor (LHRHR) , GRP78 , glucose-regulated protein 78, HSP A5 , GRP94 , glucose-regulated protein 94, HSP 90B1 , HDL , high-density lipoprotein , Hsp70 , heat shock protein 70 , ICAM-1 , intercellular adhesion molecule 1, CD54 , IGF2R , insulin like growth factor 2 receptor, mannose-6-phosphate receptor , IL4R , interleukin-4 receptor, CD124 , KDEL , Lys-Asp-Glu-Leu peptide motif , L-DOPA , L-3,4-dihydroxyphenylalanine , LAT1 , linker for activation of T cells , LYVE-1 , lymphatic vessel endothelial hyaluronan receptor 1 , M6P , mannose-6-phosphate , M6PR , mannose-6-phosphate receptor , MELTF , melanotransferrin, CD228 , MPS , mononuclear phagocytic system, also called reticuloendothelial system (RES) , MRI , magnetic resonance imaging , Muc1 , mucin-1, CD227 , Muc7 , mucin-7 , NanoEL , nanomaterial-induced endothelial leakiness , NIR , near-infrared , NP , nanoparticle , PDGF , platelet-derived growth factor , PDGFRβ , platelet-derived growth factor receptor β , PDT , photodynamic therapy , PEG , polyethylene glycol , PET , positron emission tomography , PSCA , prostate stem cell antigen , PSMA , prostate-specific membrane antigen , PTT , photothermal therapy , QD , quantum dot , RAGE receptor , receptor for advanced glycation endproducts , RBC , red blood cell , RGD , tripeptide sequence Arg-Gly-Asp , Robo4 , Roundabout guidance receptor 4 , ROS , reactive oxygen species , SCC , squamous cell carcinoma , SMVT , sodium-dependent multivitamin transporter, Solute Carrier Family 5 Member 6, SLC5A6 , SPECT , single photon emission computed tomography , SR-B1 , scavenger receptor class B, CD36L1, SCARB1 , SSTR , somatostatin receptor , TAM , tumor-associated macrophage , TfR , transferrin receptor, CD71 , TJ , tight junction , TME , tumor microenvironment , TNF , tumor necrosis factor , TNFR , tumor necrosis factor receptor , TRAIL , tumor necrosis factor-related apoptosis-inducing ligand , TROP2 , tumor associated calcium signal transducer 2 , UCNP , upconverting nanoparticle , uPAR , urokinase plasminogen activator receptor , US , ultrasound imaging , VE-cadherin , vascular endothelial-cadherin , VEGF , vascular endothelial growth factor , VEGFR , vascular endothelial growth factor receptor, kinase insert domain receptor, KDR , ZO-1 , zonula occludens 1, tight junction protein 1 , Zot , zonula occludens toxin
-
Datenquelle:
Inhaltsverzeichnis – Band 1877, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
-
Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancerWang, Ke / Liu, Jun / Li, Yun-Long / Li, Ji-Peng / Zhang, Rui et al. | 2022
-
Biosensors as diagnostic tools in clinical applicationsLino, C. / Barrias, S. / Chaves, R. / Adega, F. / Martins-Lopes, P. / Fernandes, J.R. et al. | 2022
-
Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectivesWalhekar, Vinayak / Bagul, Chandrakant / Kumar, Dileep / Muthal, Amol / Achaiah, Garlapati / Kulkarni, Ravindra et al. | 2022
-
P2Y purinergic signaling in prostate cancer: Emerging insights into pathophysiology and therapyPhD Khalafalla, Mahmoud G. / PharmD Tran, Hung N. / PhD Khalafalla, Farid G. et al. | 2022
-
Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunitiesZhang, Congwang / Mei, Wuxuan / Zeng, Changchun et al. | 2022
-
Cyclin-dependent kinases in DNA damage responseKciuk, Mateusz / Gielecińska, Adrianna / Mujwar, Somdutt / Mojzych, Mariusz / Kontek, Renata et al. | 2022
-
Myoglobin: From physiological roles to potential implications in cancerElkholi, Islam E. / Elsherbiny, Marwa E. / Emara, Marwan et al. | 2022
-
Targeting nanoparticles to malignant tumorsSharma, Nikita / Bietar, Kais / Stochaj, Ursula et al. | 2022
-
Proteomics and metabolomics approach in adult and pediatric glioma diagnosticsPienkowski, Tomasz / Kowalczyk, Tomasz / Garcia-Romero, Noemi / Ayuso-Sacido, Angel / Ciborowski, Michal et al. | 2022
-
An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignanciesRoy, Pritam Kumar / Biswas, Angana / K., Deepak / Mandal, Mahitosh et al. | 2022
-
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancersPark, Hong-Beom / Baek, Kwang-Hyun et al. | 2022
-
Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progressionMonster, Jooske L. / Kemp, Lars J.S. / Gloerich, Martijn / van der Post, Rachel S. et al. | 2022
-
DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancerMüller, Dalma / Győrffy, Balázs et al. | 2022
-
Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancerChannon, Lily M. / Tyma, Victoria M. / Xu, Zhihong / Greening, David W. / Wilson, Jeremy S. / Perera, Chamini J. / Apte, Minoti V. et al. | 2022
-
Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCsLu, Xuemin / Lu, Xin et al. | 2022
-
Understanding initiation and progression of hepatocellular carcinoma through single cell sequencingLi, Xin-Yue / Shen, Yue / Zhang, Li / Guo, Xiao / Wu, Jian et al. | 2022
-
RUNX1 and cancerLin, Tsung-Chieh et al. | 2022
-
Metabolic tricks of cancer cellsHönigova, Katerina / Navratil, Jiri / Peltanova, Barbora / Polanska, Hana Holcova / Raudenska, Martina / Masarik, Michal et al. | 2022
-
Coagulation and inflammation in cancer: Limitations and prospects for treatmentSingh, Arun Kumar / Malviya, Rishabha et al. | 2022
-
The signaling pathways regulated by KRAB zinc-finger proteins in cancerSun, Mengying / Ju, Jiyu / Ding, Yue / Zhao, Chunling / Tian, Chunyan et al. | 2022
-
Directing CAR T cells towards the tumor vasculature for the treatment of solid tumorsAkbari, Parvin / Katsarou, Afroditi / Daghighian, Roxanna / van Mil, Lotte W.H.G. / Huijbers, Elisabeth J.M. / Griffioen, Arjan W. / van Beijnum, Judy R. et al. | 2022
-
Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principlesKoukourakis, Michael I. / Giatromanolaki, Alexandra et al. | 2022
-
Recent thymic emigrants as the bridge between thymoma and autoimmune diseasesAo, Yong-Qiang / Jiang, Jia-Hao / Gao, Jian / Wang, Hai-Kun / Ding, Jian-Yong et al. | 2022
-
Editorial Board| 2022
-
Organ-on-Chip platforms to study tumor evolution and chemosensitivityDsouza, Venzil Lavie / Kuthethur, Raviprasad / Kabekkodu, Shama Prasada / Chakrabarty, Sanjiban et al. | 2022
-
Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implicationsLiu, Na / Shi, Feng / Yang, Lifang / Liao, Weihua / Cao, Ya et al. | 2022
-
The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontierZhang, Zhilin / Tang, Dong et al. | 2022
-
Heterogeneity and dynamic of EMT through the plasticity of ribosome and mRNA translationMorin, Chloé / Moyret-Lalle, Caroline / Mertani, Hichem C. / Diaz, Jean-Jacques / Marcel, Virginie et al. | 2022
-
Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologiesChang, Lu / Li, Jinming / Zhang, Rui et al. | 2022